Merrimack Pharmaceuticals

Closed
Call
Website
1 Kendall Sq
Cambridge, MA 02139
+1 (617) 441-1000
http://www.cequentpharma.com

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles.

The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Business services, nec, nec, Services, nec, nec, Drugs and drug proprietaries

Alexion Pharmaceuticals

AVEO Pharmaceuticals Inc. is an oncology-focused biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to pursuing advanced solutions in cancer treatment through its research and development efforts. As part of its mission, AVEO emphasizes a culture of collaboration and innovation, working closely with partners and scientific advisors to enhance its therapeutic offerings. The company is driven by a passion for delivering better outcomes for patients facing the challenges of cancer. Generated from the website
Momenta Pharmaceuticals
Real estate managers, Business services, nec, nec, Services, nec, nec

Momenta Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.
Business services, nec, nec, Feathers and feather products, Drugs and drug proprietaries

Takeda Pharmaceuticals

Takeda Pharmaceuticals USA, based in Cambridge, MA, is a global pharmaceutical company dedicated to creating better health for people and a brighter future for the world. With a focus on research and development, Takeda strives to transform lives through innovative medicines in areas such as gastrointestinal and inflammation, rare diseases, oncology, neuroscience, plasma-derived therapies, and vaccines. Committed to sustainability and corporate responsibility, Takeda emphasizes access to medicines, ethical practices, and transparency in governance. Through collaboration with diverse colleagues and a patient-centered approach, Takeda continues to advance science and technology to improve healthcare outcomes worldwide. Generated from the website
United States›Massachusetts›Cambridge›Merrimack Pharmaceuticals

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.